Home Biosimilar Antibodies Immunology & Inflammation CD markers inhibitor Polatuzumab vedotin-piiq For research use only.
Not for use in humans.

Polatuzumab vedotin-piiq

Synonyms: Polatuzumab vedotin, DCDS4501A, RG7596, Polivy™

Polatuzumab vedotin-piiq (polatuzumab vedotin, DCDS4501A, RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b (a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE). It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).

Polatuzumab vedotin-piiq

CAS No. 1313206-42-6

Click to purchase the isotype control of Polatuzumab vedotin-piiq

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Polatuzumab vedotin-piiq (polatuzumab vedotin, DCDS4501A, RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b (a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE). It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).

Product Details

CAS No. 1313206-42-6
ADC antiody Polatuzumab
ADC cytotoxin MMAE
Formulation 1xPBS
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq supplier | purchase Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq cost | Polatuzumab vedotin-piiq manufacturer | order Polatuzumab vedotin-piiq | Polatuzumab vedotin-piiq distributor